Dimensional Fund Advisors
BIOA icon

Dimensional Fund Advisors’s BioAge Labs BIOA Stock Holding History

Dimensional Fund Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.54M Buy
499,916
+105,778
+27% +$1.47M ﹤0.01% 2586
2026
Q2 		$9.7M Buy
394,138
+179,592
+84% +$3.24M ﹤0.01% 2316
2026
Q1 		$3.75M Buy
+214,546
New +$4.13M ﹤0.01% 2577

Other funds holding BIOA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Alessandra Capital Management
Alessandra Capital Management Torrance, California $142M AUM 42.73% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Dimensional Fund Advisors's BIOA Position: Q3 2026 in Review

Dimensional Fund Advisors increased its BioAge Labs (BIOA) stake by 27% in Q3 2026, buying an estimated $1.47M and bringing the position to 499,916 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

Dimensional Fund Advisors first reported a position in BIOA in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.7M in Q2 2026. 45 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Dimensional Fund Advisors held 499,916 shares of BioAge Labs worth $3.54M as of Q3 2026.
  • Dimensional Fund Advisors bought 105,778 BioAge Labs shares in Q3 2026, an estimated $1.47M.
  • BioAge Labs made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2586 holding.
  • Dimensional Fund Advisors first reported a position in BioAge Labs in Q1 2026 and has held it in 3 quarters since.
  • Dimensional Fund Advisors's BioAge Labs position peaked at $9.7M in Q2 2026.
  • 45 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.